Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.63 USD | +0.55% | +10.37% | +574.12% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.